clinical trials for pancreatic cancer patients
what to know
A clinical trial is offered to eligible patients who are willing to try or test out new medications, procedures, or devices to determine their effectiveness in preventing, diagnosing, or treating cancer, and managing symptoms or treatment side effects.
These trials are the final stage of a long research process that begins in laboratories, where treatments are first studied in lab models and animals before being tested in humans. Many successful cancer treatments used today are the result of past clinical trials, contributing to longer, improved lives for patients.Your doctor can help you decide if you might be a candidate for a clinical trial. Your medical insurance company will let you know if they will cover participation in a clinical trial, however, often there is no charge to participate.We've provided links to websites that will give you specific information about pancreatic cancer-related clinical trials at hospitals in the Northeast.The National Familial Pancreatic Tumor Registry
Pancreatic cancer can sometimes run in families, and a small number of rare genetic conditions are linked to a higher risk. The National Familial Pancreas Tumor Registry (NFPTR), part of Johns Hopkins Medicine Pathology, is a research study aimed at identifying the causes of pancreatic cancer, particularly pancreatic cancer that runs in families. This research may enable early detection and lead to improved treatment, saving lives. The addition of more families to the study is critical to continue their progress. Learn More >